Transfection Reagents & Equipment Market Growth is Driven by Advances in Gene Therapy, Rising Genetic Disease Research and High-Efficiency Delivery Methods.Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ...
Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...
IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per planLAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ...
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides ...
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
An RNAi based genetic screen and subsequent analyses reveal how dyneins and small GTPases coordinate autophagosome positioning at the ncMTOC in fat cells, advancing understanding of autophagic vesicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback